Results 261 to 270 of about 169,796 (292)
Some of the next articles are maybe not open access.
Gabapentin Withdrawal Syndrome
Clinical Neuropharmacology, 2001Gabapentin (GBP) has gained wide acceptance in the treatment of pain, migraine, bipolar illness, and epilepsy. It has a relatively benign side effect profile, lacks significant drug interactions, is not liver metabolized, and is renally excreted. Herein three cases are presented that demonstrate withdrawal symptoms after abrupt discontinuation of GBP ...
openaire +2 more sources
Gamma-hydroxybutyrate withdrawal syndrome
Annals of Emergency Medicine, 2001Gamma-hydroxybutyrate (GHB) withdrawal syndrome is increasingly encountered in emergency departments among patients presenting for health care after discontinuing frequent GHB use. This report describes the characteristics, course, and symptoms of this syndrome.A retrospective review of poison center records identified 7 consecutive cases in which ...
J E, Dyer, B, Roth, B A, Hyma
openaire +2 more sources
Emergency Medicine Clinics of North America, 1990
Current studies have begun to elucidate the pathophysiology of alcoholism and its withdrawal syndrome. Newer benzodiazepines, beta-blockers, alpha-agonists, butyrophenones and calcium channel blocking agents, alone and in combination, have been studied recently in alcohol withdrawal.
openaire +2 more sources
Current studies have begun to elucidate the pathophysiology of alcoholism and its withdrawal syndrome. Newer benzodiazepines, beta-blockers, alpha-agonists, butyrophenones and calcium channel blocking agents, alone and in combination, have been studied recently in alcohol withdrawal.
openaire +2 more sources
The Alcohol Withdrawal Syndrome
New England Journal of Medicine, 1985The alcohol withdrawal syndrome, with its wide range of clinical presentations, is readily identifiable yet often overlooked in the general hospital population.
W D, Lerner, H J, Fallon
openaire +2 more sources
The cannabis withdrawal syndrome
Current Opinion in Psychiatry, 2006The demand for treatment for cannabis dependence has grown dramatically. The majority of the people who enter the treatment have difficulty in achieving and maintaining abstinence from cannabis. Understanding the impact of cannabis withdrawal syndrome on quit attempts is of obvious importance.
Alan J, Budney, John R, Hughes
openaire +2 more sources
2010
Approximately 11–15 million people report heavy alcohol use or alcohol abuse and dependence in the United States; not surprisingly, alcohol-related medical problems are commonly encountered in critically ill and injured patients. Alcohol withdrawal syndrome (AWS) consists of symptoms and signs arising in alcohol-dependent individuals, typically within ...
openaire +1 more source
Approximately 11–15 million people report heavy alcohol use or alcohol abuse and dependence in the United States; not surprisingly, alcohol-related medical problems are commonly encountered in critically ill and injured patients. Alcohol withdrawal syndrome (AWS) consists of symptoms and signs arising in alcohol-dependent individuals, typically within ...
openaire +1 more source
The alcohol withdrawal syndrome
The Lancet, 1997The alcohol withdrawal syndrome (AWS) is a set of signs and symptoms that typically develops in alcohol-dependent people within 6–24 h of their last drink. It may occur unintentionally if abstinence is enforced by illness or injury, or deliberately if the person voluntarily stops drinking because of an alcohol-related illness, or as a prelude to ...
Hall, Wayne, Zador, Deborah
openaire +3 more sources
Neonatal Opioid Withdrawal Syndrome
Obstetrics and Gynecology Clinics of North America, 2014Neonatal opioid withdrawal syndrome is common due to the current opioid addiction epidemic. Infants born to women covertly abusing prescription opioids may not be identified as at risk until withdrawal signs present. Buprenorphine is a newer treatment for maternal opioid addiction and appears to result in a milder withdrawal syndrome than methadone ...
Mary Beth, Sutter +2 more
openaire +2 more sources
The antiandrogen withdrawal syndrome
Urological Research, 1997In 1989 the unanticipated agonist effect of antiandrogens on LNCaP prostate cancer cells was detected. A "flutamide withdrawal syndrome" was first described by Kelly and Scher [15], who reported a decrease in serum prostate-specific antigen (PSA) levels after the removal of flutamide from the treatment regimen.
M P, Wirth, S E, Froschermaier
openaire +2 more sources
Inpatient alcohol withdrawal syndrome
Revista Clínica Española (English Edition), 2015A 55-year-old man was admitted for a femur fracture; an alcohol fetor was noted on admission. The following day, the patient began to experience tremors and nervousness. Intravenous haloperidol was administered. Shortly afterwards, the patient experienced two generalized seizures and then began to experience delirium and uncontrollable agitation.
R, Monte-Secades +2 more
openaire +2 more sources